LINEAGE CELL THERAPEUTICS IN's ticker is and the CUSIP is 53566P909. A total of 3 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,438 | -36.0% | 24,100 | -23.5% | 0.00% | – |
| Q2 2023 | $44,415 | +504.3% | 31,500 | +542.9% | 0.00% | – |
| Q1 2023 | $7,350 | -63.7% | 4,900 | -71.7% | 0.00% | – |
| Q4 2022 | $20,241 | -62.5% | 17,300 | -64.1% | 0.00% | – |
| Q3 2022 | $54,000 | -50.0% | 48,200 | -31.3% | 0.00% | – |
| Q1 2022 | $108,000 | -61.0% | 70,200 | -37.9% | 0.00% | – |
| Q4 2021 | $277,000 | +84.7% | 113,000 | +89.6% | 0.00% | – |
| Q3 2021 | $150,000 | -28.9% | 59,600 | -19.6% | 0.00% | – |
| Q2 2021 | $211,000 | -18.8% | 74,100 | -33.1% | 0.00% | – |
| Q1 2021 | $260,000 | -21.5% | 110,800 | -41.2% | 0.00% | -100.0% |
| Q4 2020 | $331,000 | +2264.3% | 188,300 | +1155.3% | 0.00% | – |
| Q3 2020 | $14,000 | -53.3% | 15,000 | -56.0% | 0.00% | – |
| Q2 2020 | $30,000 | +20.0% | 34,100 | +12.9% | 0.00% | – |
| Q1 2020 | $25,000 | +2400.0% | 30,200 | +1913.3% | 0.00% | – |
| Q3 2019 | $1,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 4,900 | $7,350 | 0.00% |
| SIMPLEX TRADING, LLC | 28,600 | $42 | 0.00% |